ALFENTANIL Drug Patent Profile
✉ Email this page to a colleague
When do Alfentanil patents expire, and what generic alternatives are available?
Alfentanil is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in ALFENTANIL is alfentanil hydrochloride. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the alfentanil hydrochloride profile page.
Summary for ALFENTANIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 16 |
| Clinical Trials: | 50 |
| Patent Applications: | 4,678 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ALFENTANIL |
| What excipients (inactive ingredients) are in ALFENTANIL? | ALFENTANIL excipients list |
| DailyMed Link: | ALFENTANIL at DailyMed |
Recent Clinical Trials for ALFENTANIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Second Affiliated Hospital, School of Medicine, Zhejiang University | N/A |
| Region Östergötland | Phase 4 |
| Region Jönköping County | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for ALFENTANIL
US Patents and Regulatory Information for ALFENTANIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | ALFENTANIL | alfentanil hydrochloride | INJECTABLE;INJECTION | 075221-001 | Oct 28, 1999 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
